Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.35
+0.18 (2.92%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Lifecore Biomedical Ratios and Metrics

Millions USD. Fiscal year is Jun - May.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 May '24 May '23 May '22 May '21 May '20 2015 - 2019
Market Capitalization
236172241291351311
Upgrade
Market Cap Growth
-15.12%-28.69%-17.27%-17.12%12.76%13.27%
Upgrade
Enterprise Value
361305395424566515
Upgrade
Last Close Price
6.385.627.949.8711.9710.67
Upgrade
PE Ratio
-14.29----
Upgrade
Forward PE
-25.55---22.02
Upgrade
PS Ratio
1.631.342.332.623.481.95
Upgrade
PB Ratio
105.983.196.863.311.731.35
Upgrade
P/TBV Ratio
---4.172.452.52
Upgrade
P/OCF Ratio
87.85---21.32-
Upgrade
PEG Ratio
-1.901.901.901.901.90
Upgrade
EV/Sales Ratio
2.772.373.823.815.613.22
Upgrade
EV/EBITDA Ratio
-260.06-29.8269.55-
Upgrade
EV/EBIT Ratio
----192.89-
Upgrade
Debt / Equity Ratio
2.752.423.211.711.070.97
Upgrade
Debt / EBITDA Ratio
-77.92-9.6321.0331.98
Upgrade
Asset Turnover
0.540.510.390.290.190.30
Upgrade
Inventory Turnover
2.342.141.961.460.962.05
Upgrade
Quick Ratio
1.261.021.230.220.420.47
Upgrade
Current Ratio
2.712.092.390.661.460.96
Upgrade
Return on Equity (ROE)
-83.58%20.97%-104.52%-10.65%-10.80%-8.73%
Upgrade
Return on Assets (ROA)
-3.10%-1.77%-4.67%-0.55%0.35%-1.10%
Upgrade
Return on Capital (ROIC)
-4.13%-2.71%-6.39%-0.65%0.42%-1.33%
Upgrade
Return on Capital Employed (ROCE)
----0.70%-
Upgrade
Earnings Yield
-20.91%7.00%-41.36%-40.11%-9.20%-12.26%
Upgrade
FCF Yield
-4.60%-10.56%-16.17%-18.05%-2.49%-14.04%
Upgrade
Buyback Yield / Dilution
-9.14%-22.36%-1.67%-0.59%-0.45%-1.94%
Upgrade
Updated Jan 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q